Journal of Diagnostics Concepts & Practice››2021,Vol. 20››Issue (01): 98-103.doi:10.16150/j.1671-2870.2021.01.016
• Review article •Previous ArticlesNext Articles
Received:2021-02-02Online:2021-02-25Published:2022-06-28| [1] | Cao H, Parikh TN, Zheng J. Amyopathic dermatomyositis or dermatomyositis-like skin disease: retrospective review of 16 cases with amyopathic dermatomyositis[J]. Clin Rheumatol, 2009, 28(8):979-984. doi:10.1007/s10067-009-1152-9URL |
| [2] | Sun KY, Fan Y, Wang YX, et al. Prevalence of interstitial lung disease in polymyositis and dermatomyositis: a meta-analysis from 2000 to 2020[J]. Semin Arthritis Rheum, 2021, 51(1):175-191. doi:10.1016/j.semarthrit.2020.11.009URL |
| [3] | Long K, Danoff SK. Interstitial lung disease in polymyositis and dermatomyositis[J]. Clin Chest Med, 2019, 40(3):561-572. doi:10.1016/j.ccm.2019.05.004URL |
| [4] | Waldman R, DeWane ME, Lu J. Dermatomyositis: diagnosis and treatment[J]. J Am Acad Dermatol, 2020, 82(2):283-296. doi:S0190-9622(19)32308-4pmid:31279813 |
| [5] | Cassius C, Le Buanec H, Bouaziz JD, et al. Biomarkers in adult dermatomyositis: tools to help the diagnosis and predict the clinical outcome[J]. J Immunol Res, 2019, 2019:9141420. |
| [6] | Ye S, Chen XX, Lu XY, et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study[J]. Clin Rheumatol, 2007, 26(10):1647-1654. doi:10.1007/s10067-007-0562-9URL |
| [7] | Mira-Avendano I, Abril A, Burger CD, et al. Interstitial lung disease and other pulmonary manifestations in connective tissue diseases[J]. Mayo Clin Proc, 2019, 94(2):309-325. doi:S0025-6196(18)30704-3pmid:30558827 |
| [8] | Zuo Y, Ye L, Liu M, et al. Clinical significance of radiological patterns of HRCT and their association with macrophage activation in dermatomyositis[J]. Rheumatology (Oxford), 2020, 59(10):2829-2837. doi:10.1093/rheumatology/keaa034pmid:32065646 |
| [9] | Chino H, Sekine A, Baba T, et al. Interstitial lung disea-se with anti-melanoma differentiation-associated protein 5 antibody: rapidly progressive perilobular opacity[J]. Intern Med, 2019, 58(18):2605-2613. doi:10.2169/internalmedicine.2328-18URL |
| [10] | Yamaguchi K, Yamaguchi A, Itai M, et al. Clinical features of patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis complicated by spontaneous pneumomediastinum[J]. Clin Rheumatol, 2019, 38(12):3443-3450. doi:10.1007/s10067-019-04729-5pmid:31420814 |
| [11] | Ichikado K, Suga M, Müller NL, et al. Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors[J]. Am J Respir Crit Care Med, 2002, 165(11):1551-1556. doi:10.1164/rccm.2106157URL |
| [12] | Lian X, Zou J, Guo Q, et al. Mortality risk prediction in amyopathic dermatomyositis associated with interstitial lung disease: the FLAIR model[J]. Chest, 2020, 158(4):1535-1545. doi:10.1016/j.chest.2020.04.057URL |
| [13] | Xie HQ, Zhang WW, Sun S, et al. A simplified lung ultrasound for the diagnosis of interstitial lung disease in connective tissue disease: a meta-analysis[J]. Arthritis Res Ther, 2019, 21(1):93. doi:10.1186/s13075-019-1888-9URL |
| [14] | Wang Y, Gargani L, Barskova T, et al. Usefulness of lung ultrasound B-lines in connective tissue disease-associated interstitial lung disease: a literature review[J]. Arthritis Res Ther, 2017, 19(1):206. doi:10.1186/s13075-017-1409-7URL |
| [15] | Wang Y, Chen S, Lin J, et al. Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease[J]. Rheumatology (Oxford), 2020, 59(8):2024-2029. doi:10.1093/rheumatology/kez571URL |
| [16] | Ohno Y, Koyama H, Yoshikawa T, et al. Pulmonary high-resolution ultrashort TE MR imaging: comparison with thin-section standard- and low-dose computed tomography for the assessment of pulmonary parenchyma disea-ses[J]. J Magn Reson Imaging, 2016, 43(2):512-532. doi:10.1002/jmri.25008URL |
| [17] | Pinal-Fernandez I, Pineda-Sanchez V, Pallisa-Nuñez E, et al. Fast 1.5 T chest MRI for the assessment of interstitial lung disease extent secondary to systemic sclerosis[J]. Clin Rheumatol, 2016, 35(9):2339-2345. doi:10.1007/s10067-016-3267-0pmid:27107755 |
| [18] | Lonzetti L, Zanon M, Pacini GS, et al. Magnetic resonance imaging of interstitial lung diseases: a state-of-the-art review[J]. Respir Med, 2019, 155:79-85. doi:S0954-6111(19)30229-Xpmid:31323528 |
| [19] | Yi CA, Lee KS, Han J, et al. 3-T MRI for differentiating inflammation- and fibrosis-predominant lesions of usual and nonspecific interstitial pneumonia: comparison study with pathologic correlation[J]. AJR Am J Roentgenol, 2008, 190(4):878-885. doi:10.2214/AJR.07.2833URL |
| [20] | Montesi SB, Caravan P. Novel imaging approaches in systemic sclerosis-associated interstitial lung disease[J]. Curr Rheumatol Rep, 2019, 21(6):25. doi:10.1007/s11926-019-0826-9pmid:31025121 |
| [21] | Lilleker JB, Roberts M, Diederichsen L. Cardiac involvement in inflammatory myopathies and inherited muscle diseases[J]. Curr Opin Rheumatol, 2020, 32(6):528-533. doi:10.1097/BOR.0000000000000753URL |
| [22] | Opinc AH, Makowski MA, łukasik ZM, et al. Cardiovascular complications in patients with idiopathic inflammatory myopathies: does heart matter in idiopathic inflammatory myopathies?[J]. Heart Fail Rev, 2021, 26(1):111-125. doi:10.1007/s10741-019-09909-8URL |
| [23] | Jayakumar D, Zhang R, Wasserman A, et al. Cardiac manifestations in idiopathic inflammatory myopathies: an overview[J]. Cardiol Rev, 2019, 27(3):131-137. doi:10.1097/CRD.0000000000000241pmid:30585794 |
| [24] | Liu Y, Fang L, Chen W, et al. Identification of characteristics of overt myocarditis in adult patients with idiopathic inflammatory myopathies[J]. Cardiovasc Diagn Ther, 2020, 10(3):405-420. doi:10.21037/cdt.2020.03.04URL |
| [25] | Péter A, Balogh á, Szilágyi S, et al. Echocardiographic abnormalities in new-onset polymyositis/dermatomyositis[J]. J Rheumatol, 2015, 42(2):272-281. doi:10.3899/jrheum.140626URL |
| [26] | Zhong Y, Bai W, Xie Q, et al. Cardiac function in patients with polymyositis or dermatomyositis: a three-dimensional speckle-tracking echocardiography study[J]. Int J Cardiovasc Imaging, 2018, 34(5):683-693. doi:10.1007/s10554-017-1278-9pmid:29168054 |
| [27] | Friedrich MG, Sechtem U, Schulz-Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper[J]. J Am Coll Cardiol, 2009, 53(17):1475-1487. doi:10.1016/j.jacc.2009.02.007pmid:19389557 |
| [28] | Rosenbohm A, Buckert D, Gerischer N, et al. Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography[J]. J Neurol, 2015, 262(4):949-956. doi:10.1007/s00415-014-7623-1pmid:25673126 |
| [29] | Yu L, Sun J, Sun J, et al. Early detection of myocardial involvement by T(1) mapping of cardiac MRI in idiopat-hic inflammatory myopathy[J]. J Magn Reson Imaging, 2018, 48(2):415-422. doi:10.1002/jmri.25945URL |
| [30] | Xu Y, Sun J, Wan K, et al. Multiparametric cardiovascular magnetic resonance characteristics and dynamic changes in myocardial and skeletal muscles in idiopathic inflammatory cardiomyopathy[J]. J Cardiovasc Magn Reson, 2020, 22(1):22. doi:10.1186/s12968-020-00616-0URL |
| [31] | Weng MY, Lai EC, Kao Yang YH. Increased risk of coronary heart disease among patients with idiopathic inflammatory myositis: a nationwide population study in Taiwan[J]. Rheumatology (Oxford), 2019, 58(11):1935-1941. doi:10.1093/rheumatology/kez076URL |
| [32] | Escárcega RO, Lipinski MJ, García-Carrasco M, et al. Inflammation and atherosclerosis: cardiovascular evaluation in patients with autoimmune diseases[J]. Autoimmun Rev, 2018, 17(7):703-708. doi:S1568-9972(18)30110-1pmid:29730525 |
| [33] | Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology[J]. Circulation, 2006, 114(16):1761-1791. doi:10.1161/CIRCULATIONAHA.106.178458URL |
| [34] | Carruthers EC, Choi HK, Sayre EC, et al. Risk of deep venous thrombosis and pulmonary embolism in indivi-duals with polymyositis and dermatomyositis: a general population-based study[J]. Ann Rheum Dis, 2016, 75(1):110-116. doi:10.1136/annrheumdis-2014-205800pmid:25193998 |
| [35] | Fang YF, Wu YJ, Kuo CF, et al. Malignancy in dermatomyositis and polymyositis: analysis of 192 patients[J]. Clin Rheumatol, 2016, 35(8):1977-1984. doi:10.1007/s10067-016-3296-8URL |
| [36] | Selva-O'Callaghan A, Martinez-Gómez X, Trallero-Araguás E, et al. The diagnostic work-up of cancer-associated myositis[J]. Curr Opin Rheumatol, 2018, 30(6):630-636. doi:10.1097/BOR.0000000000000535pmid:29965856 |
| [37] | Hoesly PM, Sluzevich JC, Jambusaria-Pahlajani A, et al. Association of antinuclear antibody status with clinical features and malignancy risk in adult-onset dermatomyositis[J]. J Am Acad Dermatol, 2019, 80(5):1364-1370. doi:S0190-9622(18)32913-Xpmid:30458207 |
| [38] | Galimberti F, Li Y, Husni EM, et al. Dermatomyositis and malignancy: a proposal for evidence-based malignancy screening guidelines[J]. J Am Acad Dermatol, 2016, 74(5):AB170. |
| [39] | Leatham H, Schadt C, Chisolm S, et al. Evidence supports blind screening for internal malignancy in dermatomyositis: data from 2 large US dermatology cohorts[J]. Medicine (Baltimore), 2018, 97(2):e9639. doi:10.1097/MD.0000000000009639URL |
| [40] | Huang ZG, Gao BX, Chen H, et al. An efficacy analysis of whole-body magnetic resonance imaging in the diagnosis and follow-up of polymyositis and dermatomyositis[J]. PLoS One, 2017, 12(7):e0181069. doi:10.1371/journal.pone.0181069URL |
| [41] | Selva-O'Callaghan A, Grau JM, Gámez-Cenzano C, et al. Conventional cancer screeningversusPET/CT in dermatomyositis/polymyositis[J]. Am J Med, 2010, 123(6):558-562. doi:10.1016/j.amjmed.2009.11.012pmid:20569766 |
| [42] | Maliha PG, Hudson M, Abikhzer G, et al.18F-FDG PET/CTversusconventional investigations for cancer scree-ning in autoimmune inflammatory myopathy in the era of novel myopathy classifications[J]. Nucl Med Commun, 2019, 40(4):377-382. doi:10.1097/MNM.0000000000000981pmid:30664602 |
| [43] | Matuszak J, Blondet C, Hubelé F, et al. Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity[J]. Rheumatology (Oxford), 2019:kez040. |
| [44] | Li Y, Zhou Y, Wang Q. Multiple values of18F-FDG PET/CT in idiopathic inflammatory myopathy[J]. Clin Rheumatol, 2017, 36(10):2297-2305. doi:10.1007/s10067-017-3794-3URL |
| [45] | Nakamura N, Izumi R, Hoshi Y, et al. FDG-PET detects extensive calcinosis cutis in anti-NXP2 antibody-positive dermatomyositis[J]. Rheumatology (Oxford), 2019, 58(10):1888. doi:10.1093/rheumatology/kez083pmid:30879053 |
| [46] | Selva-O'Callaghan A, Gil-Vila A, Simó-Perdigó M, et al. PET scan: nuclear medicine imaging in myositis[J]. Curr Rheumatol Rep, 2019, 21(11):64. doi:10.1007/s11926-019-0864-3pmid:31754890 |
| No related articles found! |
| Viewed | ||||||
| Full text |
|
|||||
| Abstract |
|
|||||
